Practical considerations when treating chronic hepatitis E in solid organ transplant recipients

被引：0

作者：

Choi, David K. ^{[1
]}

Martin, Michelle T. ^{[1
]}

Chacra, Wadih ^{[2
]}

Chan, Christine ^{[2
]}

Koppe, Sean ^{[2
]}

Landers, Lisa ^{[2
]}

Naveed, Ammara ^{[2
]}

Mikolajczyk, Adam E. ^{[2
]}

机构：

[1] Univ Illinois, Coll Pharm, 833 S Wood St,Suite 164,M-C 886, Chicago, IL 60612 USA

[2] Univ Illinois, Dept Med, Div Gastroenterol & Hepatol, Chicago, IL USA

来源：

INTERNATIONAL JOURNAL OF CLINICAL PHARMACY | 2021年 / 43卷 / 03期

关键词：

Hepatitis E virus; Liver transplant; Ribavirin; Transplant;

D O I：

10.1007/s11096-020-01195-x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Hepatitis E virus (HEV) can lead to chronic infections in immunosuppressed patients. The use of ribavirin to treat chronic HEV has been well-established in case reports and guidelines. However, practical approaches to the use of this antiviral treatment in a post-transplant patient, including drug interactions, dosing adjustments, and monitoring parameters, are lacking. Thus, we present our real-world approach to the use of ribavirin to treat chronic HEV in a solid organ transplant recipient.

引用

页码：753 / 755

页数：3

共 50 条

[31] Therapeutic plasma exchange as a method of transmission of Hepatitis E Virus in solid organ transplant recipients
Mallet, Vincent
Roque-Afonso, Anne-Marie
Sberro, Rebecca
Vallet-Pichard, Anais
Deau, Benedicte
Portal, Alix
Hauser, Lisette
Legendre, Christophe M.
Pol, Stanislas
HEPATOLOGY, 2013, 58 : 1291A - 1291A
[32] Characteristics of Autochthonous Hepatitis E Virus Infection in Solid-Organ Transplant Recipients in France
Legrand-Abravanel, Florence
Kamar, Nassim
Sandres-Saune, Karine
Garrouste, Cyril
Dubois, Martine
Mansuy, Jean-Michel
Muscari, Fabrice
Sallusto, Federico
Rostaing, Lionel
Izopet, Jacques
JOURNAL OF INFECTIOUS DISEASES, 2010, 202 (06): : 835 - 844
[33] Isavuconazole for Treating Invasive Mould Disease in Solid Organ Transplant Recipients
Silva, Jose Tiago
Husain, Shahid
Aguado, Jose Maria
TRANSPLANT INTERNATIONAL, 2023, 36
[34] Pharmacologic Considerations for Solid Organ Transplant Recipients Who Become Pregnant
Casale, Jillian P.
Doligalski, Christina T.
PHARMACOTHERAPY, 2016, 36 (09): : 971 - 982
[35] Australian transplant recipients are at risk of chronic hepatitis E
Newcombe, James P.
McGinn, Stella
Wong, Bruce
Darbar, Archie
Kotsiou, George
MEDICAL JOURNAL OF AUSTRALIA, 2017, 206 (07)
[36] Chronic hepatitis E infection in lung transplant recipients
Riezebos-Brilman, Annelies
Puchhammer-Stockl, Elisabeth
van der Weide, Hinke Y.
Haagsma, Elizabeth B.
Jaksch, Peter
Bejvl, Isabella
Niesters, Hubert G.
Verschuuren, Erik A. M.
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (03): : 341 - 346
[37] HEPATITIS E VIRUS-ASSOCIATED CRYOGLOBULINEMIA IN SOLID-ORGAN-TRANSPLANT RECIPIENTS: A PROSPECTIVE STUDY
Marion, O.
Abravanel, F.
Esposito, L.
Lhomme, S.
Del Bello, A.
Izopet, J.
Kamar, N.
TRANSPLANT INTERNATIONAL, 2018, 31 : 9 - 9
[38] Serologic responses to hepatitis C virus in solid organ transplant recipients
Preiksaitis, JK
Cockfield, SM
Fenton, JM
Burton, NI
Chui, LWL
TRANSPLANTATION, 1997, 64 (12) : 1775 - 1780
[39] Hepatitis E Virus-Associated Cryoglobulinemia in Solid-Organ-Transplant Recipients: A Prospective Study
Marion, O.
Abravanel, F.
Esposito, L.
Lhomme, S.
Del Bello, A.
Izopet, J.
Kamar, N.
AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 288 - 288
[40] Viral Hepatitis Recommendations for Solid-Organ Transplant Recipients and Donors
Faria, Luciana Costa
Benedita Terrabuio, Debora Raquel
Leblebicioglu, Hakan
Huprikar, Shirish
TRANSPLANTATION, 2018, 102 (02) : S66 - S71

← 1 2 3 4 5 →